We are live on ! Find out more
IMA

ImageneBio Inc
IMA

34 hedge funds and large institutions have $69.8M invested in ImageneBio Inc in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 9

0% more ownership

Funds ownership: 6.03% → 6.04% (+0%)

16% less capital invested

Capital invested by funds: $82.8M → $69.8M (-$13M)

19% less funds holding

Funds holding: 42 → 34 (-8)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

80% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 10

Holders
34
Holders Change
-8
Holders Change %
-19.05%
% of All Funds
0.55%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
2
Increased
10
Reduced
9
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$3.19M
2
CA
CHI Advisors
New York
+$1.13M
3
Verition Fund Management
Verition Fund Management
Connecticut
+$749K
4
State Street
State Street
Massachusetts
+$51.1K
5
Millennium Management
Millennium Management
New York
+$27.2K

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$4.77M
2
HM
HealthCor Management
New York
-$781K
3
BlackRock
BlackRock
New York
-$524K
4
E
Ergoteles
New York
-$221K
5
Morgan Stanley
Morgan Stanley
New York
-$127K
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$27K +$27.2K +850 New
Bank of America
27
Bank of America
North Carolina
$24.2K +$22.6K +708 +1,388%
Morgan Stanley
28
Morgan Stanley
New York
$9.76K -$127K -3,987 -93%
BWM
29
Baystate Wealth Management
Massachusetts
$8K – – –
JP Morgan Chase
30
JP Morgan Chase
New York
$2K -$4.19K -131 -64%
Citigroup
31
Citigroup
New York
$1.86K +$32 +1 +2%
Wells Fargo
32
Wells Fargo
California
$718 +$32 +1 +5%
FFA
33
Farther Finance Advisors
California
$133 +$128 +4 New
Dimensional Fund Advisors
34
Dimensional Fund Advisors
Texas
$77 +$9.43K +295 +14%
Point72 Asset Management
35
Point72 Asset Management
Connecticut
– -$4.77M -111,958 Closed
HM
36
HealthCor Management
New York
– -$781K -18,340 Closed
Qube Research & Technologies (QRT)
37
Qube Research & Technologies (QRT)
United Kingdom
– -$68K -1,600 Closed
Goldman Sachs
38
Goldman Sachs
New York
– -$44K -1,036 Closed
Zurich Cantonal Bank
39
Zurich Cantonal Bank
Switzerland
– -$9K -206 Closed
BNP Paribas Financial Markets
40
BNP Paribas Financial Markets
France
– -$3.46K -81 Closed
MA
41
MUFG Americas
New York
– -$2K -38 Closed
CUAMC
42
China Universal Asset Management Company
China
– -$1K -28 Closed
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
– -$1K -19 Closed
1
2

IMA Hedge Fund Activity: Q4 2022 in Review

34 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q4 2022, worth a combined $69.8M — down 16% from $82.8M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of IMA and 2 opened new positions — a net loss of 8 holders — while 9 trimmed existing stakes and 10 added.

The largest buyer was Fidelity Investments, adding an estimated $3.19M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $4.77M sold.

  • 34 institutional investors held ImageneBio Inc (IMA) as of Q4 2022, down from 42 in Q3 2022.
  • Funds reported $69.8M of ImageneBio Inc stock for Q4 2022, down 16% quarter-over-quarter.
  • 2 funds opened new ImageneBio Inc positions in Q4 2022 and 10 closed out, a net change of -8 holders.
  • The largest ImageneBio Inc buyer in Q4 2022 was Fidelity Investments, an estimated $3.19M added.
  • The largest ImageneBio Inc seller in Q4 2022 was Point72 Asset Management, an estimated $4.77M sold.

Based on aggregated 13F filings for Q4 2022.